Blue Moon Reports High-Grade Germanium, Gallium, Copper Assays from Apex Project; Targets Q3-2027 DSO Sales
BMM has more than doubled off its 52-week low of $2.2.
Summary
Blue Moon Metals announced positive assay results from its Apex project, revealing high-grade germanium, gallium, and copper, and is targeting Q3-2027 for direct shipping ore sales.
Key Events · Product Development and Regulatory · BMM
-
High-Grade Assay Results
Maiden bulk sample from the Apex project yielded 0.180% germanium, 0.0273% gallium, and 1.96% copper, following the acquisition of Apex on March 16, 2026.
-
Near-Term Commercialization Strategy
Blue Moon is exploring direct shipping ore (DSO) sales from Apex, driven by the high-grade mineralization and unsolicited interest from major users and producers of germanium and gallium products.
-
Targeted Production Timeline
Permitting activities are ongoing with a target completion in Q2-2027, and discussions for contract mining have begun, aiming for potential DSO sales to commence as early as Q3-2027.
-
Strategic Market Impact
The Apex project could potentially supply nearly 100% of the domestic U.S. germanium demand at a mining rate of 150 tpd, capitalizing on recent material price increases for germanium and gallium.
Analysis · BMM · Energy & Transportation
Blue Moon Metals has reported strong initial assay results from its recently acquired Apex project, showing high grades of critical metals like germanium, gallium, and copper. The company is actively pursuing near-term commercialization through direct shipping ore (DSO) sales, with a target to begin by Q3-2027. This development is significant as it could establish a new revenue stream and position Blue Moon as a key supplier of germanium to the U.S. domestic market, especially given the recent material price increases for these strategic metals.
At the time of this filing, BMM was trading at $5.61 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $484.8M. The 52-week trading range was $2.20 to $8.63. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.